Qube Research & Technologies (QRT)
IRMD icon

Qube Research & Technologies (QRT)’s iRadimed IRMD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
157,199
+73,750
+88% +$6.72M 0.01% 1051
2026
Q1 		$8.03M Buy
83,449
+22,491
+37% +$2.25M 0.01% 1408
2025
Q4 		$5.93M Buy
60,958
+4,132
+7% +$354K 0.01% 1664
2025
Q3 		$4.04M Buy
56,826
+8,289
+17% +$552K ﹤0.01% 1884
2025
Q2 		$2.9M Buy
48,537
+964
+2% +$52.8K ﹤0.01% 2014
2025
Q1 		$2.5M Buy
47,573
+1,182
+3% +$66.4K ﹤0.01% 1869
2024
Q4 		$2.55M Buy
46,391
+12,232
+36% +$644K ﹤0.01% 1782
2024
Q3 		$1.72M Buy
34,159
+11,162
+49% +$515K ﹤0.01% 1814
2024
Q2 		$1.01M Buy
22,997
+6,086
+36% +$259K ﹤0.01% 1889
2024
Q1 		$744K Buy
16,911
+11,426
+208% +$505K ﹤0.01% 2318
2023
Q4 		$260K Buy
5,485
+2,720
+98% +$114K ﹤0.01% 2658
2023
Q3 		$123K Buy
+2,765
New +$128K ﹤0.01% 2588

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IRMD Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its iRadimed (IRMD) stake by 88% in Q2 2026, buying an estimated $6.72M and bringing the position to 157,199 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #1051.

Qube Research & Technologies (QRT) first reported a position in IRMD in Q3 2023 and has held it in 12 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Qube Research & Technologies (QRT) held 157,199 shares of iRadimed worth $15M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 73,750 iRadimed shares in Q2 2026, an estimated $6.72M.
  • iRadimed made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1051 holding.
  • Qube Research & Technologies (QRT) first reported a position in iRadimed in Q3 2023 and has held it in 12 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.